Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients

Free Radic Biol Med. 2007 Feb 1;42(3):353-62. doi: 10.1016/j.freeradbiomed.2006.11.001. Epub 2006 Nov 6.

Abstract

Hepatic oxidative stress occurs in chronic hepatitis C (CH-C), but little is known about its producing mechanisms and precise role in the pathogenesis of the disease. To determine the relevance of hepatic oxidatively generated DNA damage in CH-C, 8-hydroxy-2'-deoxyguanosine (8-OHdG) adducts were quantified in liver biopsy specimens by immunohistochemical staining, and its relationship with clinical, biochemical, and histological parameters, and treatment response was assessed in 40 CH-C patients. Hepatic 8-OHdG counts were significantly correlated with serum transaminase levels (r=0.560, p=0.0005) and histological grading activity (p=0.0013). Remarkably, 8-OHdG levels were also significantly related to body and hepatic iron storage markers (vs serum ferritin, r=0.565, p=0.0004; vs hepatic total iron score, r=0.403, p=0.0119; vs hepatic hepcidin messenger RNA, r=0.516, p=0.0013). Baseline hepatic oxidative stress was more prominent in nonsustained virological responder (non-SVR) than in SVR to interferon (IFN)/ribavirin treatment (50.8 vs 32.7 cells/10(5) microm2, p=0.0086). After phlebotomy, hepatic 8-OHdG levels were significantly reduced from 53.4 to 21.1 cells/10(5) microm2 (p=0.0125) with concomitant reductions of serum transaminase and iron-related markers in CH-C patients. In conclusion, this study showed that hepatic oxidatively generated DNA damage frequently occurs and is strongly associated with increased iron deposition and hepatic inflammation in CH-C patients, suggesting that iron overload is an important mediator of hepatic oxidative stress and disease progression in chronic HCV infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine
  • Adult
  • Aged
  • Alanine Transaminase / blood
  • Antimicrobial Cationic Peptides / blood
  • Antiviral Agents / therapeutic use
  • Aspartate Aminotransferases / blood
  • DNA Adducts / metabolism*
  • DNA Damage*
  • Deoxyguanosine / analogs & derivatives*
  • Deoxyguanosine / metabolism
  • Drug Therapy, Combination
  • Female
  • Ferritins / blood
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / metabolism*
  • Hepcidins
  • Humans
  • Interferons / therapeutic use
  • Iron Overload / metabolism*
  • Liver / drug effects
  • Liver / metabolism
  • Male
  • Middle Aged
  • Oxidative Stress*
  • Ribavirin / therapeutic use

Substances

  • Antimicrobial Cationic Peptides
  • Antiviral Agents
  • DNA Adducts
  • HAMP protein, human
  • Hepcidins
  • Ribavirin
  • 8-Hydroxy-2'-Deoxyguanosine
  • Ferritins
  • Interferons
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Deoxyguanosine